Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
Philip J. Mease, Proton Rahman, Alice B. Gottlieb, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie L. Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang, Désirée van der Heijde, Iain B. McInnes
Topics & Concepts
MedicinePsoriatic arthritisPlaceboInternal medicineClinical endpointRheumatologyArthritisPlacebo-controlled studyClinical trialGastroenterologyDouble blindPathologyAlternative medicineSpondyloarthritis Studies and TreatmentsPsoriasis: Treatment and PathogenesisRheumatoid Arthritis Research and Therapies